Immutep Limited Stock Today
| PRRUF Stock | USD 0.20 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Immutep is trading at 0.2 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.2. Immutep has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Immutep Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 879.09 M outstanding shares. More on Immutep Limited
Moving together with Immutep Pink Sheet
| 0.66 | NVO | Novo Nordisk AS | PairCorr |
| 0.65 | NONOF | Novo Nordisk AS | PairCorr |
| 0.73 | CSLLY | CSL | PairCorr |
| 0.74 | CMXHF | CSL Limited | PairCorr |
| 0.74 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Immutep Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Immutep Pink Sheet Highlights
| CEO | Marc Voigt |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Immutep Limited [PRRUF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 171.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immutep's market, we take the total number of its shares issued and multiply it by Immutep's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Immutep Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 879.09 M outstanding shares.
Immutep Limited has accumulated about 80 M in cash with (30.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Immutep Probability Of Bankruptcy
Ownership AllocationImmutep Limited has a total of 879.09 Million outstanding shares. Immutep retains 4.61 (percent) of its outstanding shares held by insiders and 24.04 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Immutep Ownership Details
Immutep Limited Risk Profiles
| Mean Deviation | 0.6539 | |||
| Standard Deviation | 3.02 | |||
| Variance | 9.14 | |||
| Risk Adjusted Performance | (0.03) |
Immutep Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immutep without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Immutep Corporate Management
| Frederic MD | Chief Officer | Profile | |
| Deanne LLB | Gen COO | Profile | |
| Indira Naidu | Joint Sec | Profile | |
| Shengfei Fang | F Sec | Profile | |
| Christian Mueller | Director Affairs | Profile |
Other Information on Investing in Immutep Pink Sheet
Immutep financial ratios help investors to determine whether Immutep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immutep with respect to the benefits of owning Immutep security.